Blueprint Medicines (BPMC) PT Raised to $122 at Wedbush

January 15, 2020 6:26 AM EST Send to a Friend

Wedbush analyst David Nierengarten raised ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Blueprint Medicines (BPMC) PT Raised to $122 at Wedbush

Member Login

Free News Feed